Mistral and n8n backer Redalpine closes $250M fund

Redalpine, a pan-European venture capital firm founded in Zurich in 2006, has closed its largest early-stage fund to date, a $250 million fund known as RAC VIII. The firm, which now boasts offices in Berlin, London, and Silicon Valley, has a portfolio of high-profile European startups such as Mistral, N26, Basecamp Research, and Proxima Fusion.

With a team that is half composed of scientists, Redalpine plans to invest primarily in seed and Series A stage startups, ranging from $1 million to $15 million each. The firm intends to lead or co-lead these investments, with a focus on sectors including robotics and AI for drug discovery. RAC VIII is 25% larger than its predecessor, RAC VII, which closed in 2024 and was worth $200 million.

Redalpine aims to back between 15 and 20 startups in total, with a particular emphasis on UK-based ventures. Sebastian Becker, general partner at Redalpine, remarked that AI is currently leveling the playing field, with Europe's strength in understanding underlying science and solving complex problems being a significant advantage.

The firm notes that startups backed by RAC VII, nearly 50% of which are UK-based, have collectively raised over $1.1 billion in funding since their inception.